Oakwood Village, Ohio-based ViewRay, Inc. announces that Dartmouth-Hitchcock Health in New Hampshire has begun patient treatments with the MRIdian MRI-Guided Therapy System, a radiation therapy device that combines advancements in precision radiation delivery and MR-guidance.

As the largest health care system and employer in New Hampshire, Dartmouth-Hitchcock Health is committed to providing the highest quality of care to the nearly two million community members it serves. The addition of MRIdian brings MRI-guided radiation therapy closer to home for patients throughout the region and opens new opportunities for research and clinical applications.

“The integration of a radiation therapy system that’s guided by MRI gives us optimal soft-tissue visualization and is key to remaining at the forefront of cancer innovation,” says Bassem Zaki, MD, interim section chief, radiation oncology, and associate professor of medicine, Geisel School of Medicine, Dartmouth. “Furthermore, the ability to adapt the treatment plan to the uniqueness of each patient while they’re on the treatment table takes cancer treatment to a whole new level of precision and accuracy.”

Currently 38 MRIdian systems are installed at hospitals around the world, where they are used to treat a wide variety of solid tumors and are the focus of numerous ongoing research efforts.